RARA CRAFT DATABASE for FDA Medical Devices

What Is a Retrained AI Compared With Before It Goes Live? Seven PCCPs from September 2026, One Retraining Daily

日本語版

Gleamer's chest X-ray CADe, ChestView US (K252486), names two comparators in its PCCP. A retrained model is deployed only if it is non-inferior, on every primary endpoint, to both the originally cleared model and the most recently deployed one. FDA's PCCP guidance for AI-enabled device software functions recommends testing against "both the original device" and "the last modified version of the device," and ChestView's condition is that recommendation written into a plan. Among the 510(k) Summaries of the seven AI-enabled devices cleared with a PCCP in September 2026, this is the one that names both comparators.

Numeric acceptance criteria could be confirmed in one Summary of the seven as well. ProNova Solutions' proton therapy QA software, VIRTUE QA (K260597), lists gamma pass rates and spot-position tolerances, and its retraining cadence is daily. The other six write "predefined acceptance criteria" and leave it there. What is being compared here is the public Summaries, not the plans FDA reviewed. A Summary without numbers does not mean a plan without numeric criteria. But for anyone who has to understand a predicate's PCCP from public documents alone, how far each one can be read is useful in itself.

September's seven are the largest single month among the 36 PCCP-flagged records that RA Craft Database has confirmed as AI/ML from January to September 2026 (RA Craft Database records; see the note at the end for how they were counted). This is part two of our monthly PCCP series. Part one covered all eighteen September PCCPs; this part takes the seven AI plans and reads them item by item against the guidance.

RA Craft Database is an independent service and is not affiliated with or endorsed by the U.S. FDA. Articles are for general information on product development and regulatory research; they are not legal or regulatory advice for a specific device. Official FDA documents remain the authoritative source.

← All articles